Johnson & Johnson Reports Earnings, Notably Lowers EOY Outlook
Johnson & Johnson reported a miss on its Q1 earnings just shy of analyst expectations. The pharmaceutical giant also noted that it has an excess of COVID-19 vaccines and that it will be lowering its end-of-year earnings outlook for 2022.
Chris Stafford, haunted house expert and CEO of Thirteenth Floor Entertainment, reveals the business behind Halloween’s biggest scares and immersive attractions
Efraim Grinberg, Chairman and CEO of Movado Group, discusses keeping iconic watch brands relevant, expanding its portfolio and reaching a new generation.
Artificial intelligence company Anthropic is asking a full federal appeals court in Washington, D.C., to reconsider a ruling upholding the Pentagon’s decision.
Bank Of America is facing more than 1.2 billion dollars in penalties after federal regulators found major failures in its anti-money-laundering controls.
Jason Miller, Professor of Supply Chain Management at Michigan State University, explains why stronger regional supply chains are key to buying American.
